| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| Alcohol / Addiction / Illegal Drugs News | |
| How To Cure A New Year's Hangover Loyola University Health System family physician Dr. Aaron Michelfelder offers the following tips on how to avoid the misery of a New Year's hangover:Before the party:-- Plan to drink moderately -- a maximum of five drinks for men and three drinks for women during a minimum three-hour period. | 01 Jan 2012 |
| Alzheimer's / Dementia News | |
| Why Older People Lose Their Memory The stereotype of the old forgetful person whose memory often fails him is widely held, but the reason for its appearance was never really pinpointed. Much like gray hair and wrinkles, it was just thought to be part of growing old. | 01 Jan 2012 |
| Cancer / Oncology News | |
| Ring In A New Healthier You In 2012 With the start of a new year, Dana-Farber Cancer Institute experts are encouraging people to ring in new healthy habits and offer a number of free and low-cost strategies to help people maintain good health and possibly reduce various cancer risks. | 01 Jan 2012 |
| Self-Regulation Of The Immune System Suppresses Defense Against Cancer It is vital that the body's own immune system does not overreact. If its key players, the helper T cells, get out of control, this can lead to autoimmune diseases or allergies. An immune system overreaction against infectious agents may even directly damage organs and tissues. | 01 Jan 2012 |
| Cardiovascular / Cardiology News | |
| TriReme Medical, Inc. Receives FDA 510(K) Clearance For Chocolate PTA Balloon Catheter TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. | 01 Jan 2012 |
| Janssen Research & Development Submits Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce Secondary Cardiovascular Events Janssen Research & Development, LLC (JRD) announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO® (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS). | 01 Jan 2012 |
| First Canadian Patients Treated With TriVascular Ovation™ Abdominal Stent Graft System TriVascular, Inc. of Santa Rosa, California, announced the first Canadian patients treated with its Ovation™ Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy. | 01 Jan 2012 |
| Clinical Trials / Drug Trials News | |
| Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise In Open-Label Extension Study Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that its neurosteroid ganaxolone which is currently under study for the treatment of partial onset seizures (POS), reported positive data in the open-label extension follow up to the company's Phase 2 clinical trial. | 01 Jan 2012 |
| Human Trials Initiated For New HIV Vaccine In the first clinical trial of an injectable vaccine containing trimeric HIV envelope protein (gp140) relevant to the predominant strain of HIV in Africa, researchers from four UK academic centers (St George's University London, Imperial College, Hull York Medical School (HYMS; University of York) and the Medical Research Council Clinical Trial Unit) and from the Infectious Disease Research Institute (IDRI) have come together to evaluate whether the vaccine is safe for use in human volunteers. | 01 Jan 2012 |
| Jennerex Announces First Patient Treated In Phase 2a Clinical Trial Of JX-594 As A Neoadjuvant Therapy In Colorectal Cancer Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver. | 01 Jan 2012 |
| Colorectal Cancer News | |
| Jennerex Announces First Patient Treated In Phase 2a Clinical Trial Of JX-594 As A Neoadjuvant Therapy In Colorectal Cancer Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver. | 01 Jan 2012 |
| Endocrinology News | |
| Obesity-Induced Brain Changes May Be Reason Weight Control Is So Hard The biggest obstacle to the successful treatment of obesity is the tendency to regain weight lost through diet and exercise, and evidence is increasing that this could be due to physiological causes. | 01 Jan 2012 |
| Epilepsy News | |
| Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise In Open-Label Extension Study Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that its neurosteroid ganaxolone which is currently under study for the treatment of partial onset seizures (POS), reported positive data in the open-label extension follow up to the company's Phase 2 clinical trial. | 01 Jan 2012 |
| Heart Disease News | |
| TriReme Medical, Inc. Receives FDA 510(K) Clearance For Chocolate PTA Balloon Catheter TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. | 01 Jan 2012 |
| Janssen Research & Development Submits Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce Secondary Cardiovascular Events Janssen Research & Development, LLC (JRD) announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO® (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS). | 01 Jan 2012 |
| First Canadian Patients Treated With TriVascular Ovation™ Abdominal Stent Graft System TriVascular, Inc. of Santa Rosa, California, announced the first Canadian patients treated with its Ovation™ Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy. | 01 Jan 2012 |
| HIV / AIDS News | |
| Human Trials Initiated For New HIV Vaccine In the first clinical trial of an injectable vaccine containing trimeric HIV envelope protein (gp140) relevant to the predominant strain of HIV in Africa, researchers from four UK academic centers (St George's University London, Imperial College, Hull York Medical School (HYMS; University of York) and the Medical Research Council Clinical Trial Unit) and from the Infectious Disease Research Institute (IDRI) have come together to evaluate whether the vaccine is safe for use in human volunteers. | 01 Jan 2012 |
| Immune System / Vaccines News | |
| Human Trials Initiated For New HIV Vaccine In the first clinical trial of an injectable vaccine containing trimeric HIV envelope protein (gp140) relevant to the predominant strain of HIV in Africa, researchers from four UK academic centers (St George's University London, Imperial College, Hull York Medical School (HYMS; University of York) and the Medical Research Council Clinical Trial Unit) and from the Infectious Disease Research Institute (IDRI) have come together to evaluate whether the vaccine is safe for use in human volunteers. | 01 Jan 2012 |
| Self-Regulation Of The Immune System Suppresses Defense Against Cancer It is vital that the body's own immune system does not overreact. If its key players, the helper T cells, get out of control, this can lead to autoimmune diseases or allergies. An immune system overreaction against infectious agents may even directly damage organs and tissues. | 01 Jan 2012 |
| IT / Internet / E-mail News | |
| Taking A Predictive Approach To Identifying Adverse Drug Reactions In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict adverse drug reactions. | 01 Jan 2012 |
| Even Limited Telemedicine Could Improve Developing Health A lack of infrastructure in developing countries, and particularly in rural areas, often ensures that healthcare provision is absent. Research published in the International Journal of Services, Economics and Management by a team at Howard University in Washington DC suggests a solution to this insidious problem involving the development of telemedicine. | 01 Jan 2012 |
| Lung Cancer News | |
| Lung Cancer Alliance Calls 2011 "The Turning Point" Lung Cancer Alliance (LCA) President Laurie Fenton-Ambrose predicted that because of major breakthroughs this year in screening, treatment and research, 2011 will be defined as the turning point year for lung cancer. | 01 Jan 2012 |
| Roswell Park Researcher Aims To Develop Screening Test For Lung Cancer Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage. | 01 Jan 2012 |
| Medical Devices / Diagnostics News | |
| First Canadian Patients Treated With TriVascular Ovation™ Abdominal Stent Graft System TriVascular, Inc. of Santa Rosa, California, announced the first Canadian patients treated with its Ovation™ Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy. | 01 Jan 2012 |
| Mental Health News | |
| UNC Study Could Lead To A Treatment For Angelman Syndrome Results of a new study from the University of North Carolina at Chapel Hill may help pave the way to a treatment for a neurogenetic disorder often misdiagnosed as cerebral palsy or autism.Known as Angelman syndrome, or AS, its most characteristic feature is the absence or near absence of speech throughout the person's life. | 01 Jan 2012 |
| Neurology / Neuroscience News | |
| Sea Snails Help Scientists Explore A Possible Way To Enhance Memory Efforts to help people with learning impairments are being aided by a species of sea snail known as Aplysia californica. The mollusk, which is used by researchers to study the brain, has much in common with other species including humans. | 01 Jan 2012 |
| New Clues As To Why Some Older People May Be Losing Their Memory New research links 'silent strokes,' or small spots of dead brain cells, found in about one out of four older adults to memory loss in the elderly. The study is published in the January 3, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. | 01 Jan 2012 |
| Why Older People Lose Their Memory The stereotype of the old forgetful person whose memory often fails him is widely held, but the reason for its appearance was never really pinpointed. Much like gray hair and wrinkles, it was just thought to be part of growing old. | 01 Jan 2012 |
| Obesity-Induced Brain Changes May Be Reason Weight Control Is So Hard The biggest obstacle to the successful treatment of obesity is the tendency to regain weight lost through diet and exercise, and evidence is increasing that this could be due to physiological causes. | 01 Jan 2012 |
| Obesity / Weight Loss / Fitness News | |
| VIVUS Announces Date Of FDA Advisory Committee Review Of Qnexa For The Treatment Of Obesity VIVUS, Inc. (NASDAQ: VVUS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012. | 01 Jan 2012 |
| Obesity-Induced Brain Changes May Be Reason Weight Control Is So Hard The biggest obstacle to the successful treatment of obesity is the tendency to regain weight lost through diet and exercise, and evidence is increasing that this could be due to physiological causes. | 01 Jan 2012 |
| Pain / Anesthetics News | |
| Double Check Dose Before Giving Acetaminophen To Infants, FDA The US Food and Drug Administration (FDA) is urging consumers to double check the label on liquid acetaminophen products marketed to infants and children before giving it to them. The popular pain reliever is marketed under various brands, including Tylenol, PediaCare, Triaminic and Little Fevers. | 01 Jan 2012 |
| Pediatrics / Children's Health News | |
| 12 Ways To Get Fit With Your Kids In 2012 This year, make sure your New Year's fitness resolution includes your kids. Doing so could make working out and losing weight a lot more fun, according to fitness expert Michael Berry.Berry, Chair of the Health and Exercise Science Department at Wake Forest University, said fitness with the kids must include more than a predictable schedule. | 01 Jan 2012 |
| Double Check Dose Before Giving Acetaminophen To Infants, FDA The US Food and Drug Administration (FDA) is urging consumers to double check the label on liquid acetaminophen products marketed to infants and children before giving it to them. The popular pain reliever is marketed under various brands, including Tylenol, PediaCare, Triaminic and Little Fevers. | 01 Jan 2012 |
| Pharma Industry / Biotech Industry News | |
| VIVUS Announces Date Of FDA Advisory Committee Review Of Qnexa For The Treatment Of Obesity VIVUS, Inc. (NASDAQ: VVUS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012. | 01 Jan 2012 |
| Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise In Open-Label Extension Study Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company, announced that its neurosteroid ganaxolone which is currently under study for the treatment of partial onset seizures (POS), reported positive data in the open-label extension follow up to the company's Phase 2 clinical trial. | 01 Jan 2012 |
| Jennerex Announces First Patient Treated In Phase 2a Clinical Trial Of JX-594 As A Neoadjuvant Therapy In Colorectal Cancer Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver. | 01 Jan 2012 |
| Taking A Predictive Approach To Identifying Adverse Drug Reactions In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict adverse drug reactions. | 01 Jan 2012 |
| Pregnancy / Obstetrics News | |
| Balancing The Womb New research hopes to explain premature births and failed inductions of labour. The study by academics at the University of Bristol suggests a new mechanism by which the level of myosin phosphorylation is regulated in the pregnant uterus. | 01 Jan 2012 |
| Psychology / Psychiatry News | |
| How To Break Murphy's Law Murphy's Law is a useful scapegoat for human error: "If something can go wrong, it will." But, a new study by researchers in Canada hopes to put paid to this unscientific excuse for errors by showing that the introduction of verification and checking procedures can improve structural safety and performance and so prevent the application of the "law". | 01 Jan 2012 |
| Public Health News | |
| Taking A Predictive Approach To Identifying Adverse Drug Reactions In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict adverse drug reactions. | 01 Jan 2012 |
| Even Limited Telemedicine Could Improve Developing Health A lack of infrastructure in developing countries, and particularly in rural areas, often ensures that healthcare provision is absent. Research published in the International Journal of Services, Economics and Management by a team at Howard University in Washington DC suggests a solution to this insidious problem involving the development of telemedicine. | 01 Jan 2012 |
| Pre-Surgery Exam Rates Vary Widely Among Hospitals Hospitals vary greatly in the number of patients who see an internal medicine specialist before major non-cardiac surgery, with rates ranging from five per cent of patients to 90 per cent, new research has found. | 01 Jan 2012 |
| Regulatory Affairs / Drug Approvals News | |
| TriReme Medical, Inc. Receives FDA 510(K) Clearance For Chocolate PTA Balloon Catheter TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. | 01 Jan 2012 |
| VIVUS Announces Date Of FDA Advisory Committee Review Of Qnexa For The Treatment Of Obesity VIVUS, Inc. (NASDAQ: VVUS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012. | 01 Jan 2012 |
| Janssen Research & Development Submits Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce Secondary Cardiovascular Events Janssen Research & Development, LLC (JRD) announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO® (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS). | 01 Jan 2012 |
| Double Check Dose Before Giving Acetaminophen To Infants, FDA The US Food and Drug Administration (FDA) is urging consumers to double check the label on liquid acetaminophen products marketed to infants and children before giving it to them. The popular pain reliever is marketed under various brands, including Tylenol, PediaCare, Triaminic and Little Fevers. | 01 Jan 2012 |
| Sports Medicine / Fitness News | |
| 12 Ways To Get Fit With Your Kids In 2012 This year, make sure your New Year's fitness resolution includes your kids. Doing so could make working out and losing weight a lot more fun, according to fitness expert Michael Berry.Berry, Chair of the Health and Exercise Science Department at Wake Forest University, said fitness with the kids must include more than a predictable schedule. | 01 Jan 2012 |
| Stroke News | |
| New Clues As To Why Some Older People May Be Losing Their Memory New research links 'silent strokes,' or small spots of dead brain cells, found in about one out of four older adults to memory loss in the elderly. The study is published in the January 3, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. | 01 Jan 2012 |
| Why Older People Lose Their Memory The stereotype of the old forgetful person whose memory often fails him is widely held, but the reason for its appearance was never really pinpointed. Much like gray hair and wrinkles, it was just thought to be part of growing old. | 01 Jan 2012 |
| Water - Air Quality / Agriculture News | |
| Researchers Develop New Method Of Cleaning Toxins From The Oilsands Alberta's oilsands have water challenges. Oilsands development uses a vast amount of water and even though it's recycled multiple times, the recycling concentrates the toxins and metals leftover from extracting and upgrading the bitumen, resulting in tailings ponds that are both a lightening rod for controversy and a significant risk to the environment. | 01 Jan 2012 |
| Exploiting Trichoderma: From Food Security To Biotechnology From improving food security to their use as biotechnology power horses, Trichoderma fungi are increasingly being exploited by industry. Current advances in the field are brought together and highlighted in a special issue of Microbiology published online on 27 December. | 01 Jan 2012 |
| Southampton Researchers Help To Outline World's Land And Water Resources For Food And Agriculture Researchers from the University of Southampton have contributed to a major international United Nation's (UN) report into the current status of the world's land and water resources for food and agriculture. | 01 Jan 2012 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar